Home | Business News | Browse by Publication | P | Pharma Marketletter

GSK's Lamictal cleared for wider pediatric use.

Publication: Pharma Marketletter
Publication Date: 27-JAN-03
Format: Online - approximately 202 words
Delivery: Immediate Online Access

Article Excerpt
The US Food and Drug Administration has approved a new pediatric indication for GlaxoSmithKline's anti-epileptic drug Lamictal (lamotrigine). The product is now indicated as an add-on treatment for children aged over two with partial seizures who achieve an insufficient clinical response with optimal doses of other anticonvulsants, extending its...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Pharma Marketletter
AtheroGenics offers 6 million shares., January 27, 2003
Warburg Pincus to buy Slovakofarma., January 27, 2003
53.7% US sales leap boosts Sanofi-Synthelabo., January 27, 2003
UK NICE revises advice on B-MS' Taxol., January 27, 2003
EU unequal drug access "needs public debate"., January 27, 2003

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.